← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurexis Therapeutics, Inc.
Aurora, CO
$4,166,381
Total funding
3
Grants
Funding over time
peak $2.1M · FY2021–25$2.5M$1.9M$1.3M$625K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,166,381 · 3
By mechanism
R44$2,771,586 · 1
U44$898,650 · 1
R43$496,145 · 1
Investigators at Neurexis Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IND-enabling studies for a potent and efficient neuroprotective drug$1,833,347
R44 · FY2025 · NS
IND-enabling studies for a potent and efficient neuroprotective drug$938,239
R44 · FY2024 · NS
Preparing for IND-enabling safety studies for a potent and efficient neuroprotective drug.$496,145
R43 · FY2021 · NS
Comparative testing of tatCN19o for neuroprotection in rodent tMCAo$299,550
U44 · FY2024 · NS
Comparative testing of tatCN19o for neuroprotection in rodent tMCAo$299,550
U44 · FY2025 · NS
Comparative testing of tatCN19o for neuroprotection in rodent tMCAo$299,550
U44 · FY2023 · NS